论文部分内容阅读
目的调查奥曲肽临床应用情况,评价其合理性,以促进临床合理用药。方法选取2015年1~12月医院使用奥曲肽的住院患者289例,对奥曲肽的用药指征、用法用量、疗程、停药指征等情况进行统计及分析。结果289份病例涉及12种用药指征,但均与消化系统疾病有关,用药剂量平均为(0.80±0.40)mg/d,疗程平均为(5.60±4.89)d,多以临床症状缓解、可进食流质为停药指征。结论临床应用奥曲肽过程中,其适应证、用量、疗程不适宜的现象普遍,需要采取相关措施进行规范,以保证患者用药的安全、有效、经济。
Objective To investigate the clinical application of octreotide and evaluate the rationality of octreotide in order to promote clinical rational use of drug. Methods From January to December 2015, 289 inpatients with octreotide in hospital were enrolled. Statistics and analysis were made on the indication of octreotide, dosage, course of treatment and indications for withdrawal. Results 289 cases involved 12 kinds of medication indications, all of which were related to digestive system diseases. The average dose was (0.80 ± 0.40) mg / d and the average duration of treatment was (5.60 ± 4.89) days. Most patients were relieved of clinical symptoms, Liquid for withdrawal indications. Conclusion In the clinical application of octreotide, its indications, dosage and treatment are not suitable for the phenomenon is widespread, the need to take relevant measures to regulate, in order to ensure that patients medication safe, effective and economical.